HealthStream Yönetim

Yönetim kriter kontrolleri 4/4

HealthStream CEO'su Bobby Frist, Jan1990 tarihinde atandı, in görev süresi 34.92 yıldır. in toplam yıllık tazminatı $ 727.11K olup, şirket hissesi ve opsiyonları dahil olmak üzere 52.3% maaş ve 47.7% ikramiyelerden oluşmaktadır. şirketin hisselerinin 17.9% ine doğrudan sahiptir ve bu hisseler € 167.35M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 7.4 yıl ve 23.9 yıldır.

Anahtar bilgiler

Bobby Frist

İcra Kurulu Başkanı

US$727.1k

Toplam tazminat

CEO maaş yüzdesi	52.3%
CEO görev süresi	34.9yrs
CEO sahipliği	17.9%
Yönetim ortalama görev süresi	7.4yrs
Yönetim Kurulu ortalama görev süresi	23.9yrs

Son yönetim güncellemeleri

Recent updates

CEO Tazminat Analizi

Bobby Frist'un ücretlendirmesi HealthStream'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Sep 30 2024	n/a	n/a	US$20m
Jun 30 2024	n/a	n/a	US$18m
Mar 31 2024	n/a	n/a	US$18m
Dec 31 2023	US$727k	US$380k	US$15m
Sep 30 2023	n/a	n/a	US$13m
Jun 30 2023	n/a	n/a	US$13m
Mar 31 2023	n/a	n/a	US$12m
Dec 31 2022	US$750k	US$375k	US$12m
Sep 30 2022	n/a	n/a	US$9m
Jun 30 2022	n/a	n/a	US$7m
Mar 31 2022	n/a	n/a	US$6m
Dec 31 2021	US$642k	US$358k	US$6m
Sep 30 2021	n/a	n/a	US$7m
Jun 30 2021	n/a	n/a	US$8m
Mar 31 2021	n/a	n/a	US$9m
Dec 31 2020	US$577k	US$345k	US$14m
Sep 30 2020	n/a	n/a	US$17m
Jun 30 2020	n/a	n/a	US$18m
Mar 31 2020	n/a	n/a	US$17m
Dec 31 2019	US$617k	US$342k	US$14m
Sep 30 2019	n/a	n/a	US$14m
Jun 30 2019	n/a	n/a	US$13m
Mar 31 2019	n/a	n/a	US$14m
Dec 31 2018	US$602k	US$331k	US$13m
Sep 30 2018	n/a	n/a	US$13m
Jun 30 2018	n/a	n/a	US$12m
Mar 31 2018	n/a	n/a	US$11m
Dec 31 2017	US$533k	US$319k	US$9m

Tazminat ve Piyasa: Bobby 'nin toplam tazminatı ($USD 727.11K ), German pazarındaki benzer büyüklükteki şirketler için ortalamanın altındadır ($USD 1.46M ).

Tazminat ve Kazançlar: Bobby 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.

CEO

Bobby Frist (57 yo)

34.9yrs

Görev süresi

US$727,109

Tazminat

Mr. Robert A. Frist, Jr., also known as Bobby, is a Co-founder of Healthstream, Inc. and has been its Chief Executive Officer and Director since 1990. He serves as Member of Advisory Board at PsychHub, LLC...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Robert Frist	Co-Founder	34.9yrs	US$727.11k	17.9% € 167.3m
Scott Roberts	CFO & Senior VP	5.8yrs	US$685.90k	0.076% € 712.3k
Michael Sousa	Executive Vice President of Enterprise Applications	no data	US$955.83k	0.18% € 1.6m
Michael Collier	Executive Vice President of Corporate Strategy & Development	no data	US$834.25k	0.13% € 1.3m
Trisha Coady	Senior Vice President of Workforce Development Solutions	6.1yrs	US$706.01k	0.077% € 724.4k
Jeffrey Cunningham	Senior VP & CTO	7.4yrs	US$482.35k	0.085% € 798.8k
Mollie Condra	Vice President of Investor Relations & Communications	no data	Veri yok	Veri yok
Sneha Oakley	VP, Compliance Officer & General Counsel	no data	Veri yok	Veri yok
Scott Fenstermacher	Senior Vice President of Sales	7.4yrs	Veri yok	0.041% € 383.5k
Kevin O'Hara	Senior Vice President of Platform Solutions	no data	US$695.90k	0.034% € 314.5k
Michael McQuigg	Senior Vice President of Digital & Network Development	5.9yrs	Veri yok	0.071% € 662.9k
Arthur Newman	Senior Executive Advisor	no data	US$429.29k	Veri yok

7.4yrs

Ortalama Görev Süresi

55yo

Ortalama Yaş

Deneyimli Yönetim: HL5 'un yönetim ekibi deneyimli ve deneyimlidir ( 7.4 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Robert Frist	Co-Founder	34.9yrs	US$727.11k	17.9% € 167.3m
Thompson Dent	Lead Independent Director	29.9yrs	US$118.01k	0.44% € 4.1m
Terry Rappuhn	Independent Director	2.9yrs	US$117.50k	0.012% € 116.2k
Jeffrey McLaren	Independent Director	34.9yrs	US$110.51k	0.064% € 593.9k
William Stead	Independent Director	26.9yrs	US$113.01k	0.14% € 1.3m
Linda Rebrovick	Independent Director	23.9yrs	US$111.60k	0.18% € 1.7m
Frank Gordon	Independent Director	22.9yrs	US$112.51k	0.75% € 7.0m
Deborah Tate	Independent Director	14.9yrs	US$110.51k	0.070% € 658.7k
Alex Jahangir	Independent Director	1.5yrs	US$102.65k	0.0037% € 34.6k

23.9yrs

Ortalama Görev Süresi

67yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: HL5 'in yönetim kurulu deneyimli ve tecrübelidir (ortalama görev süresi 23.9 yıldır).

Şirket Analizi ve Finansal Veri Durumu

Veri	Son Güncelleme (UTC saati)
Şirket Analizi	2024/12/27 09:46
Gün Sonu Hisse Fiyatı	2024/12/27 00:00
Kazançlar	2024/09/30
Yıllık Kazançlar	2023/12/31

Veri Kaynakları

Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.

Paket	Veri	Zaman Çerçevesi	Örnek ABD Kaynağı ^*
Şirket Finansalları	10 yıl	Gelir tablosu Nakit akış tablosu Bilanço	SEC Form 10-K SEC Form 10-Q
Analist Konsensüs Tahminleri	+3 yıl	Finansal tahminler Analist fiyat hedefleri	Analist Araştırma Raporları Blue Matrix
Piyasa Fiyatları	30 yıl	Hisse senedi fiyatları Temettüler, Bölünmeler ve Eylemler	ICE Piyasa Verileri SEC Form S-1
Sahiplik	10 yıl	En büyük hissedarlar İçeriden öğrenenlerin ticareti	SEC Form 4 SEC Form 13D
Yönetim	10 yıl	Liderlik ekibi Yönetim Kurulu	SEC Form 10-K SEC Form DEF 14A
Önemli Gelişmeler	10 yıl	Şirket duyuruları	SEC Form 8-K

* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılır.

Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Buradan daha fazla bilgi edinin.

Analiz Modeli ve Kar Tanesi

Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntıları Github sayfamızda mevcuttur, ayrıca raporlarımızın nasıl kullanılacağına dair kılavuzlarımız ve Youtube'da eğitimlerimiz bulunmaktadır.

Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.

Endüstri ve Sektör Metrikleri

Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları 'da mevcuttur.

Analist Kaynakları

HealthStream, Inc. 14 Bu analistlerden 6, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.

Analist	Kurum
Matthew Gillmor	Baird
Vincent Colicchio	Barrington Research Associates, Inc.
Richard Close	Canaccord Genuity

HealthStream Yönetim

Yönetim kriter kontrolleri 4/4

Anahtar bilgiler

Son yönetim güncellemeleri

HealthStream, Inc., Annual General Meeting, May 30, 2024

Insider recently sold €170k worth of stock

HealthStream Announces the Addition of Dr. Alex Jahangir to the Board of Directors

HealthStream, Inc. Approves the Retirement of Michael D. Shmerling as Director

President & COO recently sold €343k worth of stock

Independent Director recently sold €81k worth of stock

Recent updates

HealthStream, Inc. (NasdaqGS:HSTM) acquired Substantially All Assets of Total Clinical Placement System and The Clinical Hub, Inc. from Cyber Healthcare Solutions, LLC for $2.25 million.

HealthStream, Inc. Revises Earnings Guidance for the Full Year 2024

HealthStream, Inc. to Report Q3, 2024 Results on Oct 21, 2024

Second quarter 2024 earnings released: EPS: US$0.14 (vs US$0.14 in 2Q 2023)

Healthstream, Inc. Approves Quarterly Cash Dividend, Payable on August 16, 2024

HealthStream, Inc. to Report Q2, 2024 Results on Jul 22, 2024

Now 21% undervalued

First quarter 2024 earnings released: EPS: US$0.17 (vs US$0.086 in 1Q 2023)

HealthStream, Inc. Reaffirms Earnings Guidance for 2024

HealthStream, Inc. to Report Q1, 2024 Results on Apr 22, 2024

HealthStream, Inc., Annual General Meeting, May 30, 2024

Upcoming dividend of US$0.028 per share

Insider recently sold €170k worth of stock

Full year 2023 earnings released: EPS: US$0.50 (vs US$0.40 in FY 2022)

HealthStream, Inc. Announces Increases Quarterly Dividend, Payable on March 22, 2024

HealthStream, Inc. to Report Q4, 2023 Results on Feb 19, 2024

Now 23% undervalued

Upcoming dividend of US$0.025 per share at 0.4% yield

Now 24% undervalued

HealthStream, Inc. Updates Earnings Guidance for the Year 2023

Third quarter 2023 earnings released: EPS: US$0.13 (vs US$0.12 in 3Q 2022)

HealthStream, Inc. to Report Q3, 2023 Results on Oct 23, 2023

HealthStream, Inc. (NasdaqGS:HSTM) announces an Equity Buyback for $10 million worth of its shares.

Second quarter 2023 earnings released: EPS: US$0.14 (vs US$0.10 in 2Q 2022)

Healthstream, Inc. Provides Revenue Guidance for the Year 2023

HealthStream Announces the Addition of Dr. Alex Jahangir to the Board of Directors

Upcoming dividend of US$0.025 per share at 0.4% yield

HealthStream, Inc. Approves the Retirement of Michael D. Shmerling as Director

President & COO recently sold €343k worth of stock

First quarter 2023 earnings released: EPS: US$0.086 (vs US$0.093 in 1Q 2022)

Upcoming dividend of US$0.025 per share at 0.4% yield

Independent Director recently sold €81k worth of stock

Full year 2022 earnings released: EPS: US$0.40 (vs US$0.18 in FY 2021)

HealthStream, Inc. to Report Q4, 2022 Results on Feb 20, 2023

HealthStream, Inc. (NasdaqGS:HSTM) acquired substantially all of the assets from Electronic Education Documentation System, LLC for $7 million.

HealthStream, Inc. (NasdaqGS:HSTM) acquired substantially all of the assets from Electronic Education Documentation System, LLC for $7 million.

Insufficient new directors

Third quarter 2022 earnings released: EPS: US$0.12 (vs US$0.048 in 3Q 2021)

HealthStream, Inc. to Report Q3, 2022 Results on Oct 24, 2022

Independent Director recently sold €118k worth of stock

Healthstream, Inc. Provides Earnings Guidance for the Year 2022

Second quarter 2022 earnings released: EPS: US$0.10 (vs US$0.077 in 2Q 2021)

HealthStream, Inc. to Report Q2, 2022 Results on Jul 25, 2022

HealthStream, Inc. (NasdaqGS:HSTM) acquired the remaining 80% stake in CloudCME, LLC for $8.1 million.

First quarter 2022 earnings released: EPS: US$0.093 (vs US$0.073 in 1Q 2021)

Insufficient new directors

HealthStream, Inc. Reiterates Earnings Guidance for the Fiscal Year 2022

HealthStream, Inc. to Report Q1, 2022 Results on Apr 25, 2022

HealthStream, Inc., Annual General Meeting, May 26, 2022

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

HealthStream, Inc. Provides Earnings Guidance for the Full Year 2022

HealthStream, Inc. to Report Q4, 2021 Results on Feb 21, 2022

HealthStream, Inc. (NasdaqGS:HSTM) acquired Substantially All Assets of Rievent Technologies for $4 million.

HealthStream, Inc. (NasdaqGS:HSTM) announces an Equity Buyback for $20 million worth of its shares.

Independent Director recently bought €88k worth of stock

Third quarter 2021 earnings released: EPS US$0.048 (vs US$0.082 in 3Q 2020)

Second quarter 2021 earnings released: EPS US$0.077 (vs US$0.11 in 2Q 2020)

Chairman recently bought €186k worth of stock

First quarter 2021 earnings released: EPS US$0.073 (vs US$0.22 in 1Q 2020)

HealthStream, Inc.Provides Earnings Guidance for the Year 2021

Independent Director recently sold €78k worth of stock

Independent Director has left the company

C. Martin Harris, M.D. Notifies HealthStream, Inc. His Decision to Resign as Member of its Board of Directors

Full year 2020 earnings released: EPS US$0.44 (vs US$0.44 in FY 2019)

Revenue beats expectations

HealthStream, Inc. to Report Q4, 2020 Results on Feb 23, 2021

HealthStream, Inc.(NasdaqGS:HSTM) dropped from Russell 2000 Growth-Defensive Index

HealthStream, Inc. (NasdaqGS:HSTM) acquired ProcessDATA, Ltd. for approximately $2 million.

HealthStream, Inc. (NasdaqGS:HSTM) acquired substantially all assets of myClinicalExchange LLC for $4.5 million.